87 related articles for article (PubMed ID: 28078580)
21. Down-regulation of normal human T cell blast activation: roles of APO2L/TRAIL, FasL, and c- FLIP, Bim, or Bcl-x isoform expression.
Bosque A; Pardo J; Martínez-Lorenzo MJ; Iturralde M; Marzo I; Piñeiro A; Alava MA; Naval J; Anel A
J Leukoc Biol; 2005 Apr; 77(4):568-78. PubMed ID: 15653751
[TBL] [Abstract][Full Text] [Related]
22. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
23. Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases.
Akkoc T; de Koning PJ; Rückert B; Barlan I; Akdis M; Akdis CA
J Allergy Clin Immunol; 2008 Mar; 121(3):652-658.e1. PubMed ID: 18328893
[TBL] [Abstract][Full Text] [Related]
24. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
[TBL] [Abstract][Full Text] [Related]
25. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
[TBL] [Abstract][Full Text] [Related]
26. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
Tóth R; Szegezdi E; Molnár G; Lord JM; Fésüs L; Szondy Z
Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
[TBL] [Abstract][Full Text] [Related]
27. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
28. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis.
Mollereau B; Blanchard D; Déas O; Dumont C; Métivier D; Bernard A; McGrew JT; Charpentier B; Vazquez A; Senik A
J Immunol; 1997 Sep; 159(6):2668-77. PubMed ID: 9300686
[TBL] [Abstract][Full Text] [Related]
29. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
[TBL] [Abstract][Full Text] [Related]
30. Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD).
Maher SG; Condron CE; Bouchier-Hayes DJ; Toomey DM
Clin Exp Immunol; 2005 Feb; 139(2):279-86. PubMed ID: 15654826
[TBL] [Abstract][Full Text] [Related]
31. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Nat Immun; 1998; 16(5-6):244-55. PubMed ID: 11061592
[TBL] [Abstract][Full Text] [Related]
32. Differential involvement of a Fas-CPP32-like protease pathway in apoptosis of TCR/CD9-costimulated, naive T cells and TCR-restimulated, activated T cells.
Park CS; Yashiro Y; Tai XG; Toyo-oka K; Hamaoka T; Yagita H; Okumura K; Neben S; Fujiwara H
J Immunol; 1998 Jun; 160(12):5790-6. PubMed ID: 9637489
[TBL] [Abstract][Full Text] [Related]
33. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis.
Miethke T; Vabulas R; Bittlingmaier R; Heeg K; Wagner H
Eur J Immunol; 1996 Jul; 26(7):1459-67. PubMed ID: 8766547
[TBL] [Abstract][Full Text] [Related]
35. CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation.
Mollereau B; Deckert M; Déas O; Rieux-Laucat F; Hirsch F; Bernard A; Fischer A; Lynch DH; Charpentier B; Le Deist F; Senik A
J Immunol; 1996 May; 156(9):3184-90. PubMed ID: 8617939
[TBL] [Abstract][Full Text] [Related]
36. The TACI receptor regulates T-cell-independent marginal zone B cell responses through innate activation-induced cell death.
Figgett WA; Fairfax K; Vincent FB; Le Page MA; Katik I; Deliyanti D; Quah PS; Verma P; Grumont R; Gerondakis S; Hertzog P; O'Reilly LA; Strasser A; Mackay F
Immunity; 2013 Sep; 39(3):573-83. PubMed ID: 24012421
[TBL] [Abstract][Full Text] [Related]
37. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis.
Fournel S; Genestier L; Robinet E; Flacher M; Revillard JP
J Immunol; 1996 Nov; 157(10):4309-15. PubMed ID: 8906804
[TBL] [Abstract][Full Text] [Related]
38. Identification of Fas-L-expressing apoptotic T lymphocytes in normal human peripheral blood : in vivo suicide.
De Panfilis G; Caruso A; Sansoni P; Pasolini G; Semenza D; Torresani C
Am J Pathol; 2001 Feb; 158(2):387-91. PubMed ID: 11159176
[TBL] [Abstract][Full Text] [Related]
39. Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro.
Liu X; Feng T; Gong T; Shen C; Zhu T; Wu Q; Li Q; Li H
Biomed Res Int; 2015; 2015():317801. PubMed ID: 25984529
[TBL] [Abstract][Full Text] [Related]
40. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
Martínez-Lorenzo MJ; Anel A; Gamen S; Monle n I; Lasierra P; Larrad L; Piñeiro A; Alava MA; Naval J
J Immunol; 1999 Aug; 163(3):1274-81. PubMed ID: 10415024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
